Midterm Efficacy and Complications of  Readjustable Midurethral Sling (Remeex System) in Female Stress @entity322 With Recurrence or  XXXX .

@entity1 @entity281 @entity1690 @entity322
OBJECTIVE: To evaluate the efficacy, complications, and managements of the readjustable midurethral sling (Remeex system) for the treatment of recurrent stress @entity322 (SUI) after previous anti- @entity322 surgeries or @entity1690 ( @entity1690 ). METHODS: Between March 2008 and February 2012, 102 @entity1 , who presented with previous failed surgery or @entity1690 , were treated with the Remeex system at 4 different institutions. We retrospectively reviewed medical history, physical examination, urodynamic study, postvoiding residual volume, and/or 1-hour pad test of the @entity1 . Surgical outcomes were evaluated using the Severity Index for @entity322 . The degree of @entity1 satisfaction was assessed, and all complications were classified according to the modified Clavien classification system. RESULTS: After a mean follow-up of 27.6  months (range, 14-56 months), 91 @entity1 (89.2%) were cured and 6 @entity1 (5.9%) were improved. The @entity1 's satisfaction rate was 87.2% (89 of 102 @entity1 ). Overall, 41 @entity1 (40.2%) experienced 53 complications; 15 @entity1 (14.7%) presented de novo urgency, which was properly managed with anticholinergics, and 14 @entity1 (13.7%) underwent delayed sling readjustment for recurrent SUI (n  = 13) and urinary retention (n  = 1) during follow-up. Among 6 @entity1 (5.9%) with wound @entity281 , 4 @entity1 were successfully treated by daily dressing with antibiotics, and 2 @entity1 underwent removal of the Remeex system owing to intractable @entity281 . Most complications were classified as grade 1 (54.8%) or 2 (15.1%) and were successfully treated with minimal conservative measures. CONCLUSION: The Remeex system is a valuable adjunct for recurrent SUI after previous anti- @entity322 surgeries or @entity1690 , considering most complications are Clavien grade I or II.
